While its inaugural meeting drew just 25 scientists, PVRI has since experienced remarkable growth, now boasting a membership of over 6,300 professionals from 103 countries.

The international scope of PVRI’s mission becomes evident upon attending the congress, which attracts scientists from every corner of the globe. Much of the conference program revolved around addressing disparities in healthcare, particularly concerning pulmonary hypertension care worldwide. Heart-wrenching accounts revealed the shortage of PH centers and limited access to medication, especially in regions like Africa and South America. Nevertheless, there is cause for optimism, as scientists from these areas showcased their medical expertise during presentations, dispelling any doubts about their capabilities. Multiple sessions, such as “PH as a Global Health Issue,” “The Many Faces of PH,” and “Providing Effective Care in Low or Middle-Income Countries,” sparked meaningful discussions on the inequality in global PH healthcare, offering hope for a brighter future for PH patients worldwide.

The congress also placed significant emphasis on scientific advancements, evident through numerous presentations in categories like “Therapeutic Target Identification in PH” and “Novel Therapeutics & Clinical Trial Design.” It’s clear that exciting and promising research in the field of PH is ongoing, with the impending approval of Sotartecept holding promise for numerous novel PH therapies in the near future and the years to come.

PHA Europe, along with PHA and PHA UK, maintained a presence at the conference with booths that attracted industry partners and scientists from around the world. This platform allowed for the highlighting of our work and the establishment of valuable connections. Additionally, many PH specialists were recruited to deliver presentations within our newly established Bel Air Club.

Considerable attention was also dedicated to the PH Global Survey, known as PH GPS. PHA Europe played a pivotal role in this initiative by not only assisting in translating the survey into various languages but also actively encouraging our members to involve patients and caregivers in the survey process. This collective effort led to an impressive response rate, with over 3,300 individuals participating in the survey. The audience at the congress was clearly impressed by these substantial numbers and displayed a keen interest in the forthcoming results and conclusions of the survey.